Cliff Asness's ZYME Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 111,282 shares of Zymeworks Inc. (ZYME) worth $2.91 M, representing 0.00% of the portfolio. First purchased in 2022-Q1, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in ZYME, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2023, adding 469,466 shares. Largest reduction occurred in Q2 2024, reducing 395,230 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Zymeworks (ZYME) Holding Value Over Time
Track share changes against reported price movement
Quarterly Zymeworks (ZYME) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +20,613 | Add 22.73% | 111,282 | $26.14 |
| Q1 2026 | -406 | Reduce 0.45% | 90,669 | $25.04 |
| Q4 2025 | -61,557 | Reduce 40.33% | 91,075 | $26.33 |
| Q3 2025 | -13,511 | Reduce 8.13% | 152,632 | $17.08 |
| Q2 2025 | +117,658 | Add 242.67% | 166,143 | $12.55 |
| Q1 2025 | +22,411 | Add 85.95% | 48,485 | $11.91 |
| Q4 2024 | +1,212 | Add 4.87% | 26,074 | $14.64 |
| Q3 2024 | -69,410 | Reduce 73.63% | 24,862 | $12.55 |
| Q2 2024 | -395,230 | Reduce 80.74% | 94,272 | $8.51 |
| Q1 2024 | -196,688 | Reduce 28.66% | 489,502 | $10.52 |
| Q4 2023 | -113,489 | Reduce 14.19% | 686,190 | $10.39 |
| Q3 2023 | +330,213 | Add 70.34% | 799,679 | $6.34 |
| Q2 2023 | +469,466 | New Buy | 469,466 | $8.64 |
| Q2 2022 | -12,445 | Sold Out | 0 | $0.00 |
| Q1 2022 | +12,445 | New Buy | 12,445 | $6.59 |
Cliff Asness's Zymeworks Investment FAQs
Cliff Asness first purchased Zymeworks Inc. (ZYME) in Q1 2022, acquiring 12,445 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Zymeworks Inc. (ZYME) for 15 quarters since Q1 2022.
Cliff Asness's largest addition to Zymeworks Inc. (ZYME) was in Q2 2023, adding 469,466 shares worth $4.06 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 111,282 shares of Zymeworks Inc. (ZYME), valued at approximately $2.91 M.
As of the Q2 2026 filing, Zymeworks Inc. (ZYME) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Zymeworks Inc. (ZYME) was 799,679 shares, as reported at the end of Q3 2023.